ISPAN 8065797005Recalls & reported problems
Alcon Laboratories, Inc. · ISPAN SF6 CONSTELLATION 125GM · Class 3
- Adverse event reports
- 10
- Deaths reported
- 0
- Injuries reported
- 8
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI 00380657970056), received between May 21, 2021 and May 21, 2024 — classified as 8 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Gas Output Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem8
- Appropriate Device Problem Term/Code Not Available1
- Gas Output Problem1
Patient problems
- Inflammation2
- Intraocular Pressure Increased2
- Loss of Vision2
- No Clinical Signs, Symptoms or Conditions2
- Retinal Injury2
- Visual Impairment2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Eye Injury1
Recent adverse event reports
The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.
InjuryMay 21, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PHYSICIAN REPORTED THAT AFTER VITRECTOMY SURGERY SOME COMPLICATIONS WERE OBSERVED IN THE PATIENTS AFTER THEY ARE RECEIVING GAS IN THE EYE. ITS REPORTED THAT THERE WAS SPONTANEOUS DROPS IN INTRAOCULAR PRESSURE INTRAOPERATIVELY WHICH RESULTED IN TEMPORARY INTRAOPERATIVE DISCONNECTION OF THE CHOROID. THE CUSTOMER HAS ALSO PROVIDED THE INFORMATION WHICH STATES DUE TO THE DIAGNOSED THROMBOEMBOLIC CHANGES, VASCULAR TREATMENT WAS IMPLEMENTED DURING A FOLLOW-UP VISIT AFTER 2 WEEKS - IMPROVING RETINAL CIRCULATION. ADDITIONAL INFORMATION RECEIVED STATING THAT EIGHT PATIENTS WERE IMPACTED WITH THE REPORTED EVENT.
Patient problems: Eye Injury; Intraocular Pressure Decreased
MAUDE report 19360418 ↗InjurySep 21, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE INVESTIGATOR REPORTED IN A ABSTRACT AFTER USING SULFUR HEXAFLUORIDE (SF6) GAS TAMPONADE ON PATIENTS OPERATED FOR UNILATERAL LAMELLAR MACULAR HOLE (LMH). SOME PATIENTS EXPERIENCED POOR FINAL BEST-CORRECTED VISUAL ACUITY (BCVA).
Patient problems: Visual Impairment
MAUDE report 17787110 ↗MalfunctionSep 15, 2023Gas Output Problem; Gas Output Problem
A CUSTOMER REPORTED THAT THE AN OPHTHALMIC GAS CYLINDER WAS LEFT UNPLUGGED AND SOMETIMES THERE WAS NOT ENOUGH GAS WHEN USING IT. THE PROCEDURE DETAILS AND PATIENT IMPACT WERE NOT REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17755208 ↗InjuryAug 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NURSE REPORTED THAT POST VITREO RETINAL SURGERIES USING OPHTHALMIC GAS, PATIENTS EXPERIENCED INCREASE IN INTRAOCULAR PRESSURE AND TREATED WITH MEDICATION. THE SYMPTOMS WERE RESOLVED.
Patient problems: Intraocular Pressure Increased
MAUDE report 17556993 ↗InjuryAug 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NURSE REPORTED THAT THE PATIENT HAD AN INCREASE IN INTRAOCULAR PRESSURE POST INSTILLATION OF GAS INTO THE RIGHT EYE AFTER THE VITREORETINAL SURGERY. PATIENT RECEIVED TREATMENT (DIAMOX 500 MG PO BID AND COMBIGAN BID OD) FOR INCREASED INTRAOCULAR PRESSURE.
Patient problems: Intraocular Pressure Increased
MAUDE report 17555834 ↗InjuryMay 30, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PHYSICIAN REPORTED VIA LITERATURE REPORT ABOUT TWO PATIENTS PRESENTED WITH DECREASED VISUAL ACUITY DUE TO EPIRETINAL MEMBRANE, BOTH PATIENTS UNDERWENT VITRECTOMY AND MEMBRANE PEELING. THE VITRECTOMY OPERATION WAS UNEVENTFUL AND WAS CONCLUDED WITH THE INSERTION OF OPHTHALMIC GAS TAMPONADE. BOTH EYES WERE PSEUDOPHAKIC AND HAD NO OTHER OCULAR OR SYSTEMIC PATHOLOGY. PATIENTS WERE CONTROLLED 24 HOURS FOLLOWING THE SURGERY AND BOTH PRESENTED WITH NORMAL ANTERIOR SEGMENT EXAMINATION AND NORMAL INTRAOCULAR PRESSURE. ON THE NEXT DAY OF SURGERY BOTH PATIENTS COMPLAINED OF CENTRAL SCOTOMA, AND BOTH HAD VERY DIFFICULT LIGHT PERCEPTION. FUNDUS EXAMINATION SHOWED DEVITALIZED MACULA STRUCTURES IN THE PRESENCE OF GAS BUBBLES OCCUPYING ALMOST 100% OF THE VITREOUS CAVITY. OCT (OPTICAL COHERENCE TOMOGRAPHY) EXAMINATION DONE A FEW DAYS AFTER SURGERY REVEALED NECROTIC RETINAL TISSUE. FOUR WEEKS LATER, BOTH EYES HAD LIGHT PERCEPTION VISION, AND DEVITALIZATION OF THE CENTRAL MACULA AND SPICULE-LIKE PIGMENT CHANGES IN THE MIDPERIPHERY OF THE RETINAL IN BOTH EYES. THIS REPORT IS FOR THE SECOND PATIENT (OD) INVOLVED IN THIS EVENT.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Inflammation; Loss of Vision
MAUDE report 17018161 ↗InjuryMay 29, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PHYSICIAN REPORTED VIA LITERATURE REPORT ABOUT TWO PATIENTS PRESENTED WITH DECREASED VISUAL ACUITY DUE TO EPIRETINAL MEMBRANE, BOTH PATIENTS UNDERWENT VITRECTOMY AND MEMBRANE PEELING. THE VITRECTOMY OPERATION WAS UNEVENTFUL AND WAS CONCLUDED WITH THE INSERTION OF OPHTHALMIC GAS TAMPONADE. BOTH EYES WERE PSEUDOPHAKIC AND HAD NO OTHER OCULAR OR SYSTEMIC PATHOLOGY. PATIENTS WERE CONTROLLED 24 HOURS FOLLOWING THE SURGERY AND BOTH PRESENTED WITH NORMAL ANTERIOR SEGMENT EXAMINATION AND NORMAL INTRAOCULAR PRESSURE. ON THE NEXT DAY OF SURGERY BOTH PATIENTS COMPLAINED OF CENTRAL SCOTOMA, AND BOTH HAD VERY DIFFICULT LIGHT PERCEPTION. FUNDUS EXAMINATION SHOWED DEVITALIZED MACULA STRUCTURES IN THE PRESENCE OF GAS BUBBLES OCCUPYING ALMOST 100% OF THE VITREOUS CAVITY. OCT (OPTICAL COHERENCE TOMOGRAPHY) EXAMINATION DONE A FEW DAYS AFTER SURGERY REVEALED NECROTIC RETINAL TISSUE. FOUR WEEKS LATER, BOTH EYES HAD LIGHT PERCEPTION VISION, AND DEVITALIZATION OF THE CENTRAL MACULA AND SPICULE-LIKE PIGMENT CHANGES IN THE MIDPERIPHERY OF THE RETINAL IN BOTH EYES. THIS REPORT IS FOR THE FIRST PATIENT (OD) INVOLVED IN THIS EVENT.
Patient problems: Inflammation; Loss of Vision; Visual Impairment
MAUDE report 17017095 ↗MalfunctionFeb 15, 2023Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
A PHYSICIAN REPORTED THAT DURING A SURGERY OPHTHALMIC GAS DOES NOT LAST AS LONG AS IT USED TO IN THE PATIENTS EYE. BOTH THE REGULATOR AND OPHTHALMIC GAS TANK WERE EXCHANGED AND STILL ISSUE HAD NOT RESOLVED. THE INVOLVED EYE AND THE PATIENT IDENTIFIER ARE NOT AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16377744 ↗InjuryMay 21, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PHYSICIAN REPORTED THAT FOLLOWING A VITRECTOMY PROCEDURE TWO PATIENT'S EXPERIENCED RETINAL DAMAGE. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT NOT RECEIVED. THIS REPORT REPRESENTS PATIENT TWO OF TWO FROM THIS FACILITY.
Patient problems: Retinal Injury
MAUDE report 11863176 ↗InjuryMay 21, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PHYSICIAN REPORTED THAT FOLLOWING A VITRECTOMY PROCEDURE TWO PATIENT'S EXPERIENCED RETINAL DAMAGE. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT NOT RECEIVED. THIS REPORT REPRESENTS PATIENT ONE OF TWO FROM THIS FACILITY.
Patient problems: Retinal Injury
MAUDE report 11862984 ↗
Other Gases Used Within Eye To Place Pressure On Detached Retina devices
- ISPAN 8065797102Alcon Laboratories, Inc. · Gases Used Within Eye To Place Pressure On Detached Retina84 reports
- ISPAN 8065797103Alcon Laboratories, Inc. · Gases Used Within Eye To Place Pressure On Detached Retina38 reports
- ISPAN 8065797105Alcon Laboratories, Inc. · Gases Used Within Eye To Place Pressure On Detached Retina23 reports
- ISPAN 8065797002Alcon Laboratories, Inc. · Gases Used Within Eye To Place Pressure On Detached Retina9 reports
- ISPAN SF6 Intraocular Gas 20 g CylinderEscalon Medical Corp. · Gases Used Within Eye To Place Pressure On Detached Retina2 reports
- ISPAN 8065797101Alcon Laboratories, Inc. · Gases Used Within Eye To Place Pressure On Detached Retina1 report
- ISPAN C3F8 Intraocular Gas 20 g CylinderEscalon Medical Corp. · Gases Used Within Eye To Place Pressure On Detached Retina1 report
- ISPAN 8065797004Alcon Laboratories, Inc. · Gases Used Within Eye To Place Pressure On Detached Retina1 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.